Obesity hypoventilation syndrome in the era of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors: limitations of serum bicarbonate as a screening tool
Authors
Ari Manuel (ORCID: https://orcid.org/0000-0002-7092-1687)
Amanda J. Piper (ORCID: https://orcid.org/0000-0003-3824-6172)
Obesity hypoventilation syndrome in the era of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors: limitations of serum bicarbonate as a screening tool
Ari Manuel, Amanda J. Piper, Swapna Mandal, Nicholas Hart et al.
Journal
SLEEP
Topics
Neuroscience of respiration and sleep
article
Obesity hypoventilation syndrome in the era of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors: limitations of serum bicarbonate as a screening tool
Ari Manuel, Amanda J. Piper, Swapna Mandal, Nicholas Hart, Jean‐Louis Pépin, Babak Mokhlesi
article en
Abstract
No abstract available for this paper.
Publication Tag
SLEEPVol. 49(3)
Institutions
Rush University Medical Center (US), St Thomas' Hospital (GB), University of Liverpool (GB), Inserm (FR), Royal Free London NHS Foundation Trust (GB), Aintree University Hospitals NHS Foundation Trust (GB), Royal Prince Alfred Hospital (AU), Woolcock Institute of Medical Research (AU), Fox College (US), Sleep Research Society (US), St. Thomas Hospital (CA), Université Grenoble Alpes (FR)